Endocrine Pathology

, Volume 24, Issue 2, pp 62–68 | Cite as

Radiologic and Clinical Predictors of Malignancy in the Follicular Lesion of Undetermined Significance of the Thyroid

  • Ryan Carr
  • Berrin Ustun
  • David Chhieng
  • Kevin Schofield
  • Constantine Theoharis
  • Lynwood Hammers
  • Adebowale J. Adeniran


Various ultrasonographic characteristics of thyroid nodules have been associated with a higher likelihood of malignancy, and certain clinical features may also increase the likelihood of malignancy in patients. This study is designed to determine the ultrasonographic and clinical predictors of malignancy in the atypia of undetermined significance/follicular lesion of undetermined significance (AUS/FLUS) category. A search through the cytology files at our institution was made for cases with diagnosis of AUS/FLUS. The clinical and radiologic findings were correlated with the final surgical pathology diagnosis. A total of 140 cases of AUS/FLUS with corresponding surgical intervention were identified (112 females and 28 males). There was a 79 % malignancy rate in nodules with irregular contours, compared to 51 % in nodules with regular outlines. Nodules demonstrating calcifications showed a 57 % malignancy rate, compared to 50 % in nodules without calcifications. Sixty-one percent of cases with an ultrasonographic diagnosis of indeterminate to suspicious were malignant following surgical resection. The rates of malignancy in patients with radiation exposure, symptomatic nodules, and positive family history of thyroid cancer were 22, 59, and 33 %, respectively. BRAF mutation was demonstrated in 57 % of malignant cases and in none of benign cases. No single clinical or ultrasonographic feature or combination of features is adequately sensitive or specific to identify all malignant nodules. However, a combination of solid nodules, nodules with irregular contours, symptomatic nodules, and positive BRAF mutation has high predictive value for malignancy in patients with a cytologic diagnosis of AUS/FLUS.


Thyroid Fine needle aspiration Predictors of malignancy Follicular lesion of undetermined significance Indeterminate 


  1. 1.
    Goellner JR, Gharib H, Grant CS, Johnson DA. Fine needle aspiration cytology of the thyroid. Acta Cytol 31:587–590, 1987.PubMedGoogle Scholar
  2. 2.
    Faquin WC, Baloch ZW. Fine-Needle Aspiration of Follicular Patterned Lesions of the Thyroid: Diagnosis, Management, and Follow-Up According to National Cancer Institute (NCI) Recommendations. Diagn Cytopathol 38:731–739, 2010.PubMedGoogle Scholar
  3. 3.
    American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer—Cooper DS, Doherty GM, Haugen BR, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167–1214, 2009.Google Scholar
  4. 4.
    Cibas ES, Ali SZ. The Bethesda system for reporting thyroid cytopathology. Thyroid 19:1159–1165, 2009.PubMedCrossRefGoogle Scholar
  5. 5.
    Broome JT, Solorzano CC. The impact of atypia/follicular lesion of undetermined significance on the rate of malignancy in thyroid fine-needle aspiration: Evaluation of the Bethesda System for Reporting Thyroid Cytopathology. Surgery 150:1234–1241, 2011.PubMedCrossRefGoogle Scholar
  6. 6.
    Teixeira GV, Chikota H, Teixeira T, et al. Incidence of Malignancy in Thyroid Nodules Determined to be Follicular Lesions of Undetermined Significance on Fine-Needle Aspiration. World J Surg 68:1336–1338, 2011.Google Scholar
  7. 7.
    Cross PA, Poller D. The Bethesda thyroid terminology and progress towards international agreement on thyroid FNA cytology reporting. Cytopathology 21:71–74, 2010.PubMedCrossRefGoogle Scholar
  8. 8.
    Clark DP, Faquin WC. Thyroid cytopathology. New York: Springer, 2005.Google Scholar
  9. 9.
    Cibas ES, Ducatman BS. Cytology: diagnostic principles and clinical correlates. New York: Saunders, 2009.Google Scholar
  10. 10.
    Faquin WC. Diagnosis and Reporting of Follicular-Patterned Thyroid Lesions by Fine Needle Aspiration. Head and Neck Pathol 3:82–85, 2009.CrossRefGoogle Scholar
  11. 11.
    Baloch ZW, Livolsi VA. Follicular-patterned lesions of the thyroid: the bane of the pathologist. Am J Clin Pathol 117:143–150, 2002.PubMedCrossRefGoogle Scholar
  12. 12.
    Oertel YC, Burman K, Boyle L, et al. Integrating fine-needle aspiration into a daily practice involving thyroid disorders: The Washington Hospital Center Approach. Diagn Cytopathol 120:120–122, 2007.Google Scholar
  13. 13.
    Layfield LJ, Morton MJ, Cramer HM, et al. Implications of the proposed thyroid fine-needle aspiration category of “follicular lesion of undetermined significance”: a five-year multi-institutional analysis. Diagn Cytopathol 37:710–714, 2009.PubMedCrossRefGoogle Scholar
  14. 14.
    Baloch ZW, Cibas ES, Clark DP, et al. The National Cancer Institute Thyroid Fine Needle Aspiration State of the Science Conference: a summation. Cytojournal 5:6, 2008.PubMedCrossRefGoogle Scholar
  15. 15.
    Yang J, Schnadig V, Logrono R, et al. Fine-needle aspiration of thyroid nodules: a study of 4703 patients with histologic and clinical correlations. Cancer 111:306–315, 2007.PubMedCrossRefGoogle Scholar
  16. 16.
    Deandrea M, Ragazzoni F, Motta M, et al. Diagnostic value of a cytomorphological subclassification of follicular patterned thyroid lesions: a study of 927 consecutive cases with histological correlation. Thyroid 20:1077–1083, 2010.PubMedCrossRefGoogle Scholar
  17. 17.
    Theoharis CG, Schofield KM, Hammers L, et al. The Bethesda thyroid fine-needle aspiration classification system: year 1 at an academic institution. Thyroid 19;1215–1223, 2009.PubMedCrossRefGoogle Scholar
  18. 18.
    Jo VY, Stelow EB, Dustin SM, et al. Malignancy risk for fine-needle aspiration of thyroid lesions according to the Bethesda system for reporting thyroid cytopathology. Am J Clin Pathol 134:450–456, 2010.PubMedCrossRefGoogle Scholar
  19. 19.
    Layfield LJ, Cibas ES, Baloch ZW, et al. Thyroid fine needle aspiration cytology: a review of the National Cancer Institute state of the science symposium. Cytopathology 21:75–85, 2010.PubMedCrossRefGoogle Scholar
  20. 20.
    Adeniran AJ, Hui P, Chhieng DC, et al. BRAF Mutation Testing of Thyroid Fine-Needle Aspiration Specimens Enhances the Predictability of Malignancy in Thyroid Follicular Lesions of Undetermined Significance. Acta Cytol 55:570–575, 2011.PubMedCrossRefGoogle Scholar
  21. 21.
    Dutta S, Thaha MA, Smith DM. Do sonographic and cytological features predict malignancy in cytologically indeterminate thyroid nodules? Ann R Coll Surg Engl 93:361–364, 2011.PubMedCrossRefGoogle Scholar
  22. 22.
    Tyler DS, Winchester DJ, Caraway NP, et al. Indeterminate fine-needle aspiration biopsy of the thyroid: identification of subgroups at high risk for invasive carcinoma. Surgery 116:1054–1060, 1994.PubMedGoogle Scholar
  23. 23.
    Banks ND, Kowalski J, Tsai HL, et al. A diagnostic predictor model for indeterminate or suspicious thyroid FNA samples. Thyroid 18:933–941, 2008.PubMedCrossRefGoogle Scholar
  24. 24.
    Gharib H. Fine-needle aspiration biopsy of thyroid nodules: advantages, limitations, and effect. Mayo Clin Proc 69:44–49, 1994.PubMedCrossRefGoogle Scholar
  25. 25.
    Horne MJ, Chhieng DC, Theoharis C, et al. Thyroid follicular lesion of undetermined significance: Evaluation of the risk of malignancy using the two-tier sub-classification. Diagn Cytopathol. 40:410–415, 2012PubMedCrossRefGoogle Scholar
  26. 26.
    Sahin M, Gursoy A, Tutuncu NB, Guvener DN. Prevalence and prediction of malignancy in cytologically indeterminate thyroid nodules. Clin Endocrinol 65:514–518, 2006.CrossRefGoogle Scholar
  27. 27.
    Miller B, Burkey S, Lindberg G, et al. Prevalence of malignancy within cytologically indeterminate thyroid nodules. Am J Surg 188:459–462, 2004.PubMedCrossRefGoogle Scholar
  28. 28.
    Koike E, Noguchi S, Yamashita H, et al. Ultrasonographic characteristics of thyroid nodules: prediction of malignancy. Arch Surg 136:334–337, 2001.PubMedCrossRefGoogle Scholar
  29. 29.
    Filicori F, Keutgen XM, Buitrago D, et al. Risk stratification of indeterminate thyroid fine-needle aspiration biopsy specimens based on mutation analysis. Surgery 150:1085–1091, 2011.PubMedGoogle Scholar
  30. 30.
    Pelizzo MR, Boschin IM, Barollo S, et al. BARF analysis by fine needle aspiration biopsy of thyroid nodules improves preoperative identification of papillary thyroid carcinoma and represents a prognostic factor. A mono-institutional experience. Clin Chem Lab Med 49:325–329, 2011.PubMedCrossRefGoogle Scholar
  31. 31.
    Haugen BR, Woodmansee WW, McDermott MT. Towards improving the utility of fine-needle aspiration biopsy for the diagnosis of thyroid tumours. Clin Endocrinol 56:281–290, 2002.CrossRefGoogle Scholar
  32. 32.
    Rabaglia JL, Kabbani W, Wallace L, et al. Effect of the Bethesda system for reporting thyroid cytopathology on thyroidectomy rates and malignancy risk in cytologically indeterminate lesions. Surgery 148:1267–1272, 2010.PubMedCrossRefGoogle Scholar
  33. 33.
    Shi Y, Ding X, Klein M, et al. Thyroid fine-needle aspiration with atypia of undetermined significance: a necessary or optional category? Cancer 117:298–304, 2009.PubMedGoogle Scholar
  34. 34.
    Prasad ML, Pellegata NS, Huang Y, et al. Galectin-3, fibronectin-1, CITED-1, HBME1 and cytokeratin-19 immunohistochemistry is useful for the differential diagnosis of thyroid tumors. Mod Pathol. 18:48–57, 2005.PubMedCrossRefGoogle Scholar
  35. 35.
    Nasr MR, Mukhopadhyay S, Zhang S, Katzenstein AL. Immunohistochemical markers in diagnosis of papillary thyroid carcinoma: Utility of HBME1 combined with CK19 immunostaining. Mod Pathol. 19:1631–1637, 2006.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • Ryan Carr
    • 1
  • Berrin Ustun
    • 1
  • David Chhieng
    • 1
  • Kevin Schofield
    • 1
  • Constantine Theoharis
    • 1
  • Lynwood Hammers
    • 2
  • Adebowale J. Adeniran
    • 1
  1. 1.Department of PathologyYale University School of MedicineNew HavenUSA
  2. 2.Department of Diagnostic RadiologyYale University School of MedicineNew HavenUSA

Personalised recommendations